Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Partners In Health, Abbott and the Abbott Fund Open Nutrition Facility in Haiti


News provided by

Abbott

06 Nov, 2013, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

- Facility Produces First Shipments of Locally Sourced, Therapeutic Food to Treat Severe Malnutrition in Children

- Abbott and PIH Combine Unique, Complementary Expertise to Build Facility, Train Local Team and Drive Sustainable Development

CORPORANT, Haiti, Nov. 6, 2013 /PRNewswire/ -- Partners In Health (PIH), Abbott and its foundation, the Abbott Fund, today announced the opening of a new nutrition production facility in the Central Plateau in Haiti. The centerpiece of a broader partnership between PIH, Abbott and the Abbott Fund to help drive economic development in the region, the facility will produce "Nourimanba," a life-saving treatment for severe malnutrition in children. The first shipments of Nourimanba produced at the new facility have been distributed to PIH's clinics in the region, and are already being used to provide effective treatment for children.

Continue Reading
This image opens in the lightbox
Partners In Health, Abbott and the Abbott Fund Open Nutrition Facility in Haiti. (PRNewsFoto/Abbott) (PRNewsFoto/ABBOTT)

(Photo: http://photos.prnewswire.com/prnh/20131106/AQ11194)

"After several years of close collaboration, we are excited to achieve this significant milestone in our partnership with Abbott and the Abbott Fund. Producing Nourimanba at the new facility will help PIH and Zanmi Lasante to continue providing free, high-quality treatment for children at our clinics across the region," said Ophelia Dahl, PIH co-founder and executive director. "The impact of this partnership goes well beyond a building. As an employer and a customer for local farmers, this facility aims to spark a cluster of economic activity that is desperately needed in the region."

A New Facility, With a Broader Impact
The 18,000 square-foot Nourimanba Production Facility (Sant Prodiksyon Nourimanba in Haitian Creole) was built primarily by Haitian workers, with technical support from more than 50 Abbott engineers, scientists and other experts. Designed to meet international standards for food products, the facility includes modern laboratories and testing technology, with extensive quality and safety procedures. At the same time, the facility was built to be appropriate for Haiti, with rugged equipment that requires little maintenance.

The facility is operated and managed by Haitians, led by PIH's sister organization, Zanmi Lasante (Partners In Health in Haitian Creole). Abbott and PIH experts provided extensive training for the local team to upgrade manufacturing, production and maintenance skills, and share best practices in quality and food safety. Abbott and PIH also will continue to offer ongoing mentoring and support to ensure long-term sustainable operations.

A Life-Saving Product, Sourced From a Community of Farmers
Even prior to the earthquake in January 2010, one in three Haitian children under the age of five suffered from malnutrition. Nourimanba, a ready-to-use therapeutic food product designed to treat severe childhood malnutrition, is a high-calorie, high-protein, fortified paste that is comprised of only five ingredients: peanuts, milk powder, canola oil, sugar and vitamins. Ready to eat by the patient, Nourimanba does not require mixing with water or refrigeration, and can be given to children at home rather than in a hospital, avoiding the cost and complexity of in-patient treatment. Nourimanba produced at the new facility is provided free to any patient in need through a network of clinics supported by PIH/ZL in the Central Plateau and the Artibonite Valley.

The main ingredient in Nourimanba is locally sourced peanuts grown by Haitian farmers. Through the partnership, a pilot program is providing support for approximately 300 farmers to improve the quality and quantity of the peanut supply needed for the facility, while increasing farmer incomes and the overall competitiveness of the local peanut agricultural sector.

Looking ahead, the partnership is exploring a variety of ways to utilize excess production capacity to produce a fortified peanut butter. Revenue from peanut butter sales would be reinvested in the facility to cover the costs of Nourimanba production, with the goal of creating a social enterprise that will help sustain facility operations over the long term.

Unique Partnership Combines Complementary Expertise, Resources
Partners In Health, Abbott and the Abbott Fund have worked together on the Nourimanba partnership in Haiti since 2009, combining PIH's health care leadership, the skills and knowledge of Zanmi Lasante, more than 10,000 hours of technical support provided by expert Abbott employees, and $6.5 million in funding support from Abbott and the Abbott Fund.

"When Abbott started working with Partners In Health a few years ago, we were both looking for ways to do things differently, so we can have a greater impact in helping to bring about transformational change in Haiti," said Katherine Pickus, divisional vice president, Global Citizenship and Policy, Abbott, and vice president, the Abbott Fund. "By combining the unique expertise and resources of a non-profit organization and a leading nutrition and healthcare business, and by listening and working closely together every step of the way, we have been able to open a new facility that both produces a life-saving treatment for children and provides economic opportunity for local communities."

The new facility in Haiti builds on prior accomplishments of the ongoing partnership between PIH, Abbott and the Abbott Fund to expand access to health care in developing countries, including establishing a women's health clinic in Lascahobas, Haiti, and building a rural hospital in Malawi. The partnership also is part of Abbott's broader philanthropic work to help address critical health needs in Haiti.

To access additional information, photos and videos on the new facility and the broader partnership, please visit www.partnershipinhaiti.org.

About Partners In Health
Partners In Health is a global health organization relentlessly committed to improving the health of the poor and marginalized. PIH builds local capacity and works closely with impoverished communities to deliver high-quality health care, addressing the root causes of illness, train providers, advance research and advocate for global policy change. Ninety-three percent of the funds go to PIH programs in nine countries, including Haiti, Rwanda, Russia, Peru and Navajo Nation. Visit www.pih.org for more information.

About Abbott and the Abbott Fund
Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people. Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

The Abbott Fund is a philanthropic foundation established by Abbott in 1951. The Abbott Fund's mission is to create healthier global communities by investing in creative ideas that promote science, expand access to healthcare and strengthen communities worldwide. For more information on the Abbott Fund, visit http://www.abbottfund.org.

Note to Editors: Photos, videos and other assets are available for download and use at www.partnershipinhaiti.org

Modal title

Also from this source

New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib

New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib

Abbott (NYSE: ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving...

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib)....

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Corporate Social Responsibility

Corporate Social Responsibility

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.